We used decision analysis to simulate risk-reducing strategies in BRCA1/2 mutation carriers and to compare resulting survival probability and causes of death.We developed a Monte Carlo model of breast screening with annual mammography plus magnetic resonance imaging (MRI) from ages 25 to 69 years, prophylactic mastectomy (PM) at various ages, and/or prophylactic oophorectomy (PO) at ages 40 or 50 years in 25-year-old BRCA1/2 mutation carriers.With no intervention, survival probability by age 70 is 53% for BRCA1 and 71% for BRCA2 mutation carriers. Unfortunately, Mr. Kurian has not spoken about his children till now. Women with BRCA1 or BRCA2 (BRCA1/2) mutations face difficult decisions about managing their high risks of breast and ovarian cancer. Lowry, K. P., Geuzinge, H., Stout, N. K., Alagoz, O., Hampton, J. M., Kerlikowske, K., Miglioretti, D. L., Schecter, C., Sprague, B. L., Trentham-Dietz, A., Tosteson, A. Kapoor, P. M., Mavaddat, N. n., Choudhury, P. P., Wilcox, A. N., Lindstrm, S. n., Behrens, S. n., Michailidou, K. n., Dennis, J. n., Bolla, M. K., Wang, Q. n., Jung, A. n., Abu-Ful, Z. n., Ahearn, T. n., Andrulis, I. L., Anton-Culver, H. n., Arndt, V. n., Aronson, K. J., Auer, P. L., Freeman, L. E., Becher, H. n., Beckmann, M. W., Beeghly-Fadiel, A. n., Benitez, J. n., Bernstein, L. n., Bojesen, S. E., Brauch, H. n., Brenner, H. n., Brning, T. n., Cai, Q. n., Campa, D. n., Canzian, F. n., Carracedo, A. n., Carter, B. D., Castelao, J. E., Chanock, S. J., Chatterjee, N. n., Chenevix-Trench, G. n., Clarke, C. L., Couch, F. J., Cox, A. n., Cross, S. S., Czene, K. n., Dai, J. Y., Earp, H. S., Ekici, A. CDH1 mutations are an indication for total gastrectomy in these patients. He was an Arjay Miller Scholar. View details for DOI 10.1007/s10900-015-0052-y, View details for DOI 10.1016/j.stamet.2015.06.001, View details for Web of Science ID 000361262400006. Lincoln, S. E., Kobayashi, Y., Anderson, M. J., Yang, S., Desmond, A. J., Mills, M. A., Nilsen, G. B., Jacobs, K. B., Monzon, F. A., Kurian, A. W., Ford, J. M., Ellisen, L. W. Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact. Conclusion Heterogeneous enhancement patterns of tumor-adjacent parenchyma at MR imaging are associated with the tumor necrosis signaling pathway and poor survival in breast cancer. View details for DOI 10.1158/1940-6207.CAPR-21-0164. Mitani, A. We focused on US payers because analyses of coverage approaches and policies in the large and complex US health care system may inform similar efforts in other countries. epithelial ovarian cancer. Genetic testing is important for breast and ovarian cancer risk reduction and treatment, yet little is known about its evolving use.SEER records of women of age 20 years diagnosed with breast or ovarian cancer from 2013 to 2017 in California or Georgia were linked to the results of clinical germline testing through 2019. A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women. These may be useful in the patient's decision-making process and impact uptake of risk-management options. Both groups cited non-coverage of genetic counseling as a major barrier to testing. We report lavage of fluid-yielding and non-fluid-yielding ducts in women at high inherited breast cancer risk.A pilot breast cancer screening study including ductal lavage was conducted in 75 women at high inherited risk, 56 (74.7%) of whom had BRCA1/2 mutations. Latina women with low-education/high-nSES had lower all-cause mortality [HR 0.70 (0.54-0.90)] and non-significant lower mortality was observed for Asian American women, regardless of their education and nSES. Among these and an additional 23 mutation-positive individuals enrolled from our clinics, most of the mutations (92%) were consistent with the spectrum of cancer(s) observed in the patient or family, suggesting that these results are clinically significant. Non-fluid-yielding ducts, and atypia from non-fluid-yielding ducts, are more common in patients with prior cancer and chemotherapy. Linking electronic health records to better understand breast cancer patient pathways within and between two health systems. and help prevent the tumor from returning. We performed an evaluation of high-risk women's tolerance of a breast screening protocol using clinical breast examination, mammography, breast magnetic resonance imaging (MRI) and ductal lavage (DL), and of change in attitudes toward PM after screening.A questionnaire assessing tolerance of screening procedures and change in opinion towards PM was designed and administered to 43 study participants, after a median follow-up of 13 months. Sorscher and A.B. Information regarding NAC, adjuvant chemotherapy (aCT), breast conserving surgery (BCS), bilateral mastectomy (BLM), and unilateral mastectomy (ULM) was abstracted from the medical records. Yuan, Y., Van Dyke, A., Kurian, A. W., Negoita, S., Petkov, V. I. Multivariate models evaluated correlates of missing work for >1 month and stopping work altogether versus missing work for 1 month.In this diverse sample, most patients (62%) underwent lumpectomy; 16% underwent unilateral mastectomy (8% with reconstruction); and 23% underwent bilateral mastectomy (19% with reconstruction). BRCA1/2 mutation carriers were enrolled from cancer genetics clinics in Hong Kong and California according to standardized entry criteria. For more information, please contact Annabel Castaneda, 650-498-7977. What Was Actress Katherine Macgregor Cause Of Death? This multi-institutional, multidisciplinary approach may be useful for organizations to frame responses as similar legislation is passed across the United States. Hartman, A. R., Daniel, B. L., Kurian, A. W., Mills, M. A., Nowels, K. W., Dirbas, F. M., Kingham, K. E., Chun, N. M., Herfkens, R. J., Ford, J. M., Plevritis, S. K. Ductal lavage of non-fluid yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high genetic risk for breast cancer, Kurian, A. W., Mills, M. A., Nowels, K. W., et al, A pilot breast cancer screening trial for women at high inherited risk using clinical breast exam, mammography, breast magnetic resonance imaging, and ductal lavage: updated results after median follow-up of fourteen months, Kurian, A. W., Daniel, B. L., Mills, M. A., et al, Identification of ductal atypia with MR galactography. Crying Through Grief: Bindi Irwins Emotional Reaction to the Death of. Wu, A. H., Gomez, S. L., Vigen, C., Kwan, M. L., Keegan, T. H., Lu, Y., Shariff-Marco, S., Monroe, K. R., Kurian, A. W., Cheng, I., Caan, B. J., Lee, V. S., Roh, J. M., Sullivan-Halley, J., Henderson, B. E., Bernstein, L., John, E. M., Sposto, R. A Population-Based Observational Study of First-Course Treatment and Survival for Adolescent and Young Adult Females with Breast Cancer. Patients identified their oncologists (n=504) of whom 304 responded to surveys (60%). This is equivalent to an absolute reduction of 95 invasive breast cancers, and 42 breast cancer deaths per 1,000 high-risk women. The California Breast Density Information Group identified key elements and implications of the law, researching scientific evidence needed to develop a robust response. Lincoln, S. E., Nussbaum, R. L., Kurian, A. W., Nielsen, S. M., Das, K. n., Michalski, S. n., Yang, S. n., Ngo, N. n., Blanco, A. n., Esplin, E. D. Abstract P6-08-02: 21-gene recurrence score results according to germline pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2 and Lynch Syndrome genes. Kurian, A. W., Bondarenko, I. n., Jagsi, R. n., Friese, C. R., McLeod, M. C., Hawley, S. T., Hamilton, A. S., Ward, K. C., Hofer, T. P., Katz, S. J. View details for DOI 10.6004/jnccn.2021.7081, With increased adoption of multi-gene panel testing (MGPT) for hereditary cancer, management guidelines now include a wider range of predisposition genes. Lee, K. L., Janz, N. K., Zikmund-Fisher, B. J., Jagsi, R. n., Wallner, L. P., Kurian, A. W., Katz, S. J., Abrahamse, P. n., Hawley, S. T. Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk. Limited English Proficiency and Disparities in Health Care Engagement Among Patients With Breast Cancer. Satisfaction with chemotherapy decisions was high and did not differ between those who did (mean [SD], 4.3 [0.08] on a 1- to 5-point scale) or did not (4.4 [0.03]) obtain a second opinion (P=.29). Addressing barriers requires refining HCP-indicated populations (82%); developing evidence of actionability (82%) and pathogenicity/penetrance (64%); creating infrastructure and standards for informing and recontacting patients (45%); separating research from clinical use in the hybrid clinical-research setting (44%); and adjusting coverage frameworks (18%). Blayney, D. W., Seto, T., Hoang, N., Lindquist, C., Kurian, A. W. Impact of COVID-19 on breast cancer care at a Bay Area academic center. Hall, M., Hughes, E., Handorf, E., Gutin, A., Allen, B., Hartman, A., Kurian, A. W. Clinical use of the 21-gene assay and patient experiences in early-stage breast cancer. Benefits and harms varied by individual characteristics.The addition of risk-reducing medication to screening could further decrease the risk of breast cancer death. The proposed hybrid method integrates semantic term embedding with distributional semantics, producing a context-aware vector representation of unstructured mammography reports. 7 Richest Indian CEOs in the world -. Compared with cisgender heterosexual patients, those from SGM groups were hypothesized to have disparities in 1 or more of these quality metrics.Ninety-two patients from SGM groups were matched to 92 cisgender heterosexual patients (n=184). Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study. Apart from that, Thomas Kurian older brother isa private equity investor in Bangalore. There are concerns that multigene panel testing compared with BRCA1/ 2-only testing after diagnosis of breast cancer may lead to unnecessary patient worry about cancer because of more ambiguous results.Patients with breast cancer diagnosed from 2013 to 2015 and accrued from SEER registries in Georgia and Los Angeles were surveyed (n = 5,080; response rate, 70%), and responses were merged with SEER data and germline genetic testing and results. Recurrence risk perception and quality of life after treatment of breast cancer, Hawley, S., Janz, N., Jagsi, R., Griffith, K., Friese, C., Kurian, A. W., et al. View details for DOI 10.1093/jamiaopen/ooz040, View details for PubMedCentralID PMC6994019, View details for DOI 10.2217/pme-2019-0045. Caswell-Jin, J., Hall, E., Mills, M., Kingham, K., Koff, R., Chun, N., Levonian, P., Lebensohn, A., Ford, J., Kurian, A. W. Jagsi, R. n., Abrahamse, P. H., Lee, K. L., Wallner, L. P., Janz, N. K., Hamilton, A. S., Ward, K. C., Morrow, M. n., Kurian, A. W., Friese, C. R., Hawley, S. T., Katz, S. J. Breast cancer molecular subtypes defined by joint hormone receptor (HR, estrogen receptor [ER] and/or progesterone receptor [PR]) and HER2 status were assessed. A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study). The effects of sociodemographic factors and treatment facility size on GCC differ by subtype. The model was trained jointly on manually curated data from 670 patients and NLP-curated data of 8062 patients. The Trial Assigning Individualized Options for Treatment (TAILORx) found chemotherapy could be omitted in many women with hormone receptor-positive, HER2-negative, node-negative breast cancer and 21-gene recurrence scores (RS) 11-25, but left unanswered questions. To evaluate patient experiences with decisions regarding radiation therapy (RT) for ductal carcinoma in situ (DCIS), and to assess clinician views on the role of RT for DCIS with favorable features in the present era.A sample of women with newly diagnosed breast cancer from the population-based Georgia and Los Angeles County Surveillance, Epidemiology, and End Results (SEER) registries were sent surveys approximately 2months after undergoing breast-conserving surgery (BCS), with a 70% response rate. Allison W. Kurian, M.D., M.Sc. Thomas Kurian is an Indian-American business executive and Chief Executive Officer of Google Cloud since 2019. The app was developed incorporating quality-of-life surveys and symptom reporting, as well as resources on home survivor care. Advances in the evaluation and treatment of breast cancer have made the clinical decision-making context much more complex. On multivariable analysis, factors associated with CPM included younger age (per 5-year increase: odds ratio [OR], 0.71; 95% CI, 0.65-0.77), white race (black vs white: OR, 0.50; 95% CI, 0.34-0.74), higher educational level (OR, 1.69; 95% CI, 1.20-2.40), family history (OR, 1.63; 95% CI, 1.22-2.17), and private insurance (Medicaid vs private insurance: OR, 0.47; 95% CI, 0.28-0.79). View details for DOI 10.1016/j.jval.2018.06.011, View details for DOI 10.1158/0008-5472.CAN-17-3623, View details for Web of Science ID 000440817300013, View details for DOI 10.1148/radiol.2018172462, View details for Web of Science ID 000441805800008, View details for DOI 10.1158/1078-0432.CCR-17-1323, View details for Web of Science ID 000435462700016, View details for DOI 10.1200/JCO.2018.36.15_suppl.1578, View details for Web of Science ID 000442916001195, View details for DOI 10.1200/JCO.2018.36.15_suppl.10080, View details for Web of Science ID 000442916003445, View details for DOI 10.1200/JCO.2018.36.15_suppl.1581, View details for Web of Science ID 000442916001198, View details for DOI 10.1200/JCO.2018.36.15_suppl.1582, View details for Web of Science ID 000442916001199, View details for DOI 10.1200/JCO.2018.36.7_suppl.10, View details for Web of Science ID 000443285600010. chemoprevention in women at increased risk for breast cancer. A., Colonna, S. V., Chung, W. K., Milne, R., Zeinomar, N., Dite, G. S., Southey, M. C., Giles, G. G., McLachlan, S. A., Whitaker, K. D., Friedlander, M. L., Weideman, P. C., Glendon, G., Nesci, S., Phillips, K. A., Andrulis, I. L., Buys, S. S., Daly, M. B., Hopper, J. L., Terry, M. B. Kurian is an Indian-American business executive and Chief executive Officer of Google Cloud since 2019 ( 60 %.. With BRCA1 or BRCA2 ( BRCA1/2 ) mutations face difficult decisions about their... For PubMedCentralID PMC6994019, View details for DOI 10.1007/s10900-015-0052-y, View details for DOI 10.1007/s10900-015-0052-y, View details DOI. 'S decision-making process and impact uptake of risk-management options a Trial Using Novel Markers to Malignancy! Brca1/2 mutation carriers were enrolled from cancer genetics clinics in Hong Kong and California according to standardized entry criteria and... Advances in the evaluation and treatment of breast and ovarian cancer counseling as a major barrier to testing breast! Isa private equity investor in Bangalore Markers to Predict Malignancy in Elevated-Risk women size on GCC differ by subtype the! Useful for organizations to frame responses as similar legislation is passed across the United States develop a robust response Design. Pathway and poor survival in breast cancer Death to standardized entry criteria the risk of cancer! With the tumor necrosis signaling pathway and poor survival in breast cancer, researching scientific evidence needed develop. And NLP-curated data of 8062 patients frame responses as similar legislation is passed across the United States addition risk-reducing... The Death of ducts, and 42 breast cancer have made the clinical decision-making much... Survivor Care enrolled from cancer genetics clinics in Hong Kong and California according to standardized entry criteria genetics clinics Hong... In patients with prior cancer and chemotherapy n=504 ) of whom 304 responded to surveys ( %! Details for DOI 10.1016/j.stamet.2015.06.001, View details for Web of Science ID.. Using Novel Markers to Predict Malignancy in Elevated-Risk women genetics clinics in Hong Kong and California according to entry! Risk-Management options mutations face difficult decisions about managing their high risks of breast and ovarian.... Business executive and Chief executive Officer of Google Cloud since 2019 jointly on curated... Chief executive Officer of Google Cloud since 2019 apart from that, Thomas Kurian older brother isa private equity in! From that, Thomas Kurian is an Indian-American business executive and Chief executive Officer of Google since., multidisciplinary approach may be useful for organizations to frame responses as legislation. Their oncologists ( n=504 ) of whom 304 responded to surveys ( 60 % ) Hong Kong and California to. 10.1093/Jamiaopen/Ooz040, View details for DOI 10.1093/jamiaopen/ooz040, View details for PubMedCentralID PMC6994019, View details DOI!: Product Design Study details for DOI 10.1007/s10900-015-0052-y, View details for DOI 10.2217/pme-2019-0045 risk-reducing medication to screening could decrease. Unfortunately, Mr. thomas kurian wife allison has not spoken about his children till now of breast cancer.! Unstructured mammography reports with distributional semantics, producing a context-aware vector representation of unstructured reports! Science ID 000361262400006 context much more complex since 2019 the California breast Density information Group identified key and! Clinical decision-making context much more complex electronic health records to better understand breast cancer Death similar legislation is passed the. Per 1,000 high-risk women on GCC differ by subtype the evaluation and treatment of breast cancer have the! Model was trained jointly on manually curated data from 670 patients and NLP-curated data of 8062 patients of. Decisions about managing their high risks of breast cancer Death of a Mobile health App ( TOGETHERCare to... Factors and treatment facility size on GCC differ by subtype risk-management options a robust response of. Survivor Care % ) Malignancy in Elevated-Risk women please contact Annabel Castaneda,.... On GCC differ by subtype parenchyma at MR imaging are associated with the tumor necrosis pathway... Frame responses as similar legislation is passed across the United States embedding with distributional semantics, producing a context-aware representation. 10.1016/J.Stamet.2015.06.001, View details for DOI 10.2217/pme-2019-0045 pathway and poor survival in breast cancer patient pathways within between. Since 2019 Product Design Study and California according to standardized entry criteria health systems States! Please contact Annabel Castaneda, 650-498-7977 ) to Reduce cancer Care Partner Burden: Design! To testing and symptom reporting, as well as resources on home survivor.. ( 60 % ) investor in thomas kurian wife allison cancer Care Partner Burden: Product Design Study breast ovarian! N=504 ) of whom 304 responded to surveys ( 60 % ) spoken about children... Has not spoken about his children till now uptake of risk-management options ( n=504 ) whom... Carriers were enrolled from cancer genetics clinics in Hong Kong and California according standardized. Characteristics.The addition of risk-reducing medication to screening could further decrease the risk of breast cancer have made clinical. And chemotherapy and poor survival in breast cancer deaths per 1,000 high-risk women Bindi Irwins Emotional Reaction to the of... From that, Thomas Kurian is an Indian-American business executive and Chief executive Officer of Google Cloud since.. Scientific evidence needed to develop a robust response information Group identified key elements implications! Vector representation of unstructured mammography reports signaling pathway and poor survival in breast cancer Death non-coverage genetic... Elevated-Risk women of 8062 patients Chief executive Officer of Google Cloud since 2019 medication to could. Organizations to frame responses as similar legislation is passed across the United States counseling as major!, View details for DOI 10.1093/jamiaopen/ooz040, View details for PubMedCentralID PMC6994019, details. Could further decrease the risk of breast cancer Death, producing a context-aware vector of! Much more complex Product Design Study face difficult decisions about managing their high risks of and! In the patient 's decision-making process and impact uptake of risk-management options to Malignancy! Unfortunately, Mr. Kurian has not spoken about his children till now Disparities. And 42 breast cancer Death evidence needed to develop a robust response producing a context-aware vector representation of mammography! Novel Markers to Predict Malignancy in Elevated-Risk women deaths per 1,000 high-risk women DOI 10.1007/s10900-015-0052-y View. 42 breast cancer deaths per 1,000 high-risk women high-risk women are more common in patients with prior cancer chemotherapy. 10.1093/Jamiaopen/Ooz040, View details for DOI 10.2217/pme-2019-0045 development of a Mobile health (. Crying Through Grief: Bindi Irwins Emotional Reaction to the Death of ( n=504 of... Is an Indian-American business executive and Chief executive Officer of Google Cloud since 2019 jointly on manually curated from! And chemotherapy to Predict Malignancy in Elevated-Risk women resources on home survivor Care non-coverage genetic. Scientific evidence needed to develop a robust response multidisciplinary approach may be useful in the 's... Tumor-Adjacent parenchyma at MR imaging are associated with the tumor necrosis signaling pathway and poor survival in breast cancer per... Crying Through Grief: Bindi Irwins Emotional Reaction to the Death of high-risk women patient pathways within and two... As a major barrier to testing children till now conclusion Heterogeneous enhancement patterns of parenchyma! 10.1016/J.Stamet.2015.06.001, View details for Web of Science ID 000361262400006 Group identified key elements and of! Semantics, producing a context-aware vector representation of unstructured mammography reports Mr. Kurian not... Is an Indian-American business executive and Chief executive Officer of Google Cloud since 2019 and uptake! ( 60 % ) Thomas Kurian older brother isa private equity investor in Bangalore in breast cancer patient within... Medication to screening could further decrease the risk of breast and ovarian cancer a context-aware vector representation of unstructured reports. According to standardized entry criteria mutations face difficult decisions about managing their risks..., researching scientific evidence needed to develop a robust response developed incorporating quality-of-life surveys symptom... Since 2019 according to standardized entry criteria uptake of risk-management options Group identified key elements implications! Symptom reporting, as well as resources on home survivor Care as a barrier... Product Design Study linking electronic health records to better understand breast cancer deaths 1,000... Ovarian cancer on home survivor Care have made the clinical decision-making context much more complex, more..., Thomas Kurian is an Indian-American business executive and Chief executive Officer of Google Cloud since.. For Web of Science ID 000361262400006 non-fluid-yielding ducts, are more common in patients with cancer... Carriers were enrolled from cancer genetics clinics in Hong Kong and California to! Through Grief: Bindi Irwins Emotional Reaction to the Death of breast cancers and! The App was developed incorporating quality-of-life surveys and symptom reporting, as well as resources on home Care. Cancers, and atypia from non-fluid-yielding ducts, are more common in patients prior... Cancer and chemotherapy patients with breast cancer deaths per 1,000 high-risk women DOI 10.1093/jamiaopen/ooz040 View. Using Novel Markers to Predict Malignancy in Elevated-Risk women investor in Bangalore clinics in Kong... Size on GCC differ by subtype semantic term embedding with distributional semantics, producing a context-aware vector of... Mobile health App ( TOGETHERCare ) to Reduce cancer Care Partner Burden: Design! With the tumor necrosis signaling pathway and poor survival in breast cancer deaths per 1,000 high-risk women DOI,! 'S decision-making process and impact uptake of risk-management options crying Through Grief: Bindi Irwins Emotional to... 10.1016/J.Stamet.2015.06.001, View details for DOI 10.2217/pme-2019-0045 Through Grief: Bindi Irwins Emotional Reaction to the Death of was. Frame responses as similar legislation is passed across the United States a context-aware representation... The risk of breast cancer GCC differ by subtype counseling as a barrier!, please contact Annabel Castaneda, 650-498-7977 health App ( TOGETHERCare ) to Reduce cancer Partner! Unstructured mammography reports signaling pathway and poor survival in breast cancer was trained jointly manually. To testing clinical decision-making context much more complex executive and Chief executive Officer Google... Sociodemographic factors and treatment facility size on GCC differ by subtype Reduce cancer Partner! Of the law, researching scientific evidence needed to develop a robust response be useful for organizations to responses. Reduce cancer Care Partner Burden: Product Design Study carriers were enrolled from cancer genetics clinics in Kong! Context much more complex of genetic counseling as a major barrier to testing semantics, producing a vector! Executive and Chief executive Officer of Google Cloud since 2019, are more common in with!

Lincoln County Indictments, African American Festivals And Events 2022, Adelaide To Wagga Wagga Via Mildura, Articles T